Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Peng Li

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Biological Macromolecules|November 7, 2023
Discovery of ellagic acid as a competitive inhibitor of Src homology phosphotyrosyl phosphatase 2 (SHP2) for cancer treatment: In vitro and in silico studyChun-Hui Ma, Ji-Feng Zhao, Xu-Guang Zhang, et al.
Journal of Hepatocellular Carcinoma|February 12, 2024
RAD21: A Key Transcriptional Regulator in the Development of Residual Liver CancerJin-Shu Pang, Xiu-Mei Bai, Wei-Jun Wan, et al.
Frontiers in Medicine|September 3, 2025
Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic responseJin-Shu Pang, Yu Yang, Li Liang, et al.
Abdominal Radiology (New York)|February 5, 2025
Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinomaLi Liang, Jin-Shu Pang, Rui-Zhi Gao, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Biological Macromolecules|November 7, 2023
Discovery of ellagic acid as a competitive inhibitor of Src homology phosphotyrosyl phosphatase 2 (SHP2) for cancer treatment: In vitro and in silico studyChun-Hui Ma, Ji-Feng Zhao, Xu-Guang Zhang, et al.
Journal of Hepatocellular Carcinoma|February 12, 2024
RAD21: A Key Transcriptional Regulator in the Development of Residual Liver CancerJin-Shu Pang, Xiu-Mei Bai, Wei-Jun Wan, et al.
Frontiers in Medicine|September 3, 2025
Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic responseJin-Shu Pang, Yu Yang, Li Liang, et al.
Abdominal Radiology (New York)|February 5, 2025
Development and validation of a combined radiomic and clinical model based on contrast-enhanced ultrasound for preoperative prediction of CK19-positive hepatocellular carcinomaLi Liang, Jin-Shu Pang, Rui-Zhi Gao, et al.
Pageof 2